CIK 0001266806
- Non-accelerated filer
- Smaller reporting company
Vivani Medical, Inc.
Sign in to watch- Ticker
- VANI
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 020692322
- Phone
- +1 415-506-8462
- Business address
- 1350 S. LOOP ROAD, ALAMEDA, CA, 94502
- Former names
- SECOND SIGHT MEDICAL PRODUCTS INC, SECOUND SIGHT MEDICAL PRODUCTS INC
- Open-market buys, last 90 days
- $67,408
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$67,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-19 | OKLAND STEPHEN D Chief Commercial Officer | Grant or award · Non-Qualified Stock Option(right to buy) | +95,000 | 95,000 | ||
| 2019-02-19 | OKLAND STEPHEN D Chief Commercial Officer | Grant or award · Restricted Stock Units(RSUs) | +48,000 | 48,000 | ||
| 2019-02-19 | Blake John T Chief Financial Officer | Grant or award · Non-Qualified Stock Option(right to buy) | +163,000 | 163,000 | ||
| 2019-02-19 | Blake John T Chief Financial Officer | Grant or award · Restricted Stock Units(RSUs) | +82,000 | 82,000 | ||
| 2018-12-12 | Williams Gregg Director | Purchase | +3,275,100 | $0.92 | $3.0M | 36,255,772 |
| 2018-12-03 | Randolph Edward David Vice President - Manufacturing | Sale | −3,733 | $1.03 | $4K | 22 |
| 2018-12-03 | OKLAND STEPHEN D Chief Commercial Officer | Sale | −7,764 | $1.03 | $8K | 23,641 |
| 2018-11-30 | Randolph Edward David Vice President - Manufacturing | Grant or award | +3,733 | $0.92 | $3K | 3.76 |
| 2018-11-30 | OKLAND STEPHEN D Chief Commercial Officer | Grant or award | +7,764 | $0.92 | $7K | 31,315 |
| 2018-11-21 | McGuire Jonathan Will Chief Executive Officer | Sale | −3,920 | $1.16 | $5K | 103,753 |
| 2018-11-20 | McGuire Jonathan Will Chief Executive Officer | Option exercise | +11,875 | 107,673 | ||
| 2018-11-20 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Units (RSUs) | −11,875 | 35,625 | ||
| 2018-10-18 | Williams Gregg Director | Purchase | +2,467,767 | $1.62 | $4.0M | 32,980,672 |
| 2018-10-16 | Williams Gregg Director | Purchase | +9,988 | $1.68 | $17K | 30,512,945 |
| 2018-10-15 | Williams Gregg Director | Purchase | +7,645 | $1.63 | $12K | 30,502,957 |
| 2018-10-12 | Williams Gregg Director | Purchase | +7,694 | $1.62 | $12K | 30,495,312 |
| 2018-10-11 | Williams Gregg Director | Purchase | +11,709 | $1.60 | $19K | 30,487,618 |
| 2018-10-10 | Williams Gregg Director | Purchase | +15,875 | $1.60 | $25K | 30,475,909 |
| 2018-10-09 | Williams Gregg Director | Purchase | +10,458 | $1.64 | $17K | 30,460,034 |
| 2018-10-05 | Williams Gregg Director | Purchase | +15,875 | $1.72 | $27K | 30,449,576 |
Page 22 of 31 · 601 trades